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Abstract
The period and amplitude of biomolecular oscillators are functionally important properties in multiple contexts.
For a biomolecular oscillator, the overall constraints in how tuning of amplitude affects period, and vice versa, are
generally unclear. Here we investigate this co-variation of the period and amplitude in mathematical models of
biomolecular oscillators using both simulations and analytical approximations. We computed the amplitude-period
co-variation of eleven benchmark biomolecular oscillators as their parameters were individually varied around a
nominal value, classifying the various co-variation patterns such as a simultaneous increase/ decrease in period and
amplitude. Next, we repeated the classification using a power norm-based amplitude metric, to account for the
amplitudes of the many biomolecular species that may be part of the oscillations, finding largely similar trends.
Finally, we calculate ”scaling laws” of period-amplitude co-variation for a subset of these benchmark oscillators
finding that as the approximated period increases, the upper bound of the amplitude increases, or reaches a constant
value. Based on these results, we discuss the effect of different parameters on the type of period-amplitude co-
variation as well as the difficulty in achieving an oscillation with large amplitude and small period.
1 Introduction
Oscillatory behaviour in biomolecular systems span multiple scales of space and time. An important example is that of
circadian rhythms, which are present in both eukaryotes and prokaryotes. The classical studies of the genes period and
timeless in Drosophila melanogaster provided a genetic context to these oscillations [1]. More recently, biochemical
investigations have proved invaluable in investigating the interactions between the proteins KaiABC that are at the
core of the cyanobacterial circadian clock [2, 3]. In addition to these examples of naturally occurring oscillatory
behaviour, significant effort has been devoted to designing oscillators for synthetic biology applications inside cells
and in biochemical contexts. Examples of synthetic oscillators include the repressilator [4] and Smolen oscillator [5]
in cells, the repressilator and its variations in cell extracts [6], as well as oscillators in vitro [7–9] (please see [10] for
more examples). In these investigations of analysis and design of oscillators, mathematical models have played an
important role in understanding the underlying principles.
An important guiding principle for oscillator investigations have been the presence of a negative feedback with an
additional delay-causing mechanism, either explicitly through a time delay such as due to one or more intermediate
steps or due to a positive feedback [11–14]. Systems-level studies on these oscillators have characterized the extent
of robustness of different mechanistic realizations of oscillations [15, 16]. These have also addressed various aspects
of oscillator function. For example, a recent study showed that the amplitude-period co-variation in an oscillator
can depend on underlying mechanisms [17]. In particular, it was argued that a combination of positive and negative
feedback enables a broad range of periods for a fixed amplitude, in contrast to mechanisms based on negative feedback
alone. These studies represent important work towards connecting the structure and function of natural as well as
synthetic biomolecular oscillators.
There are at least three interesting aspects of the amplitude-period co-variation in oscillators. First, as mentioned
above, the amplitude-period co-variation has different qualitative characteristics depending on whether the oscillator
has both positive and negative feedback or only negative feedback [17]. Second, an experimental study noted the
correlation between amplitude and period [7]. Third, from energetic considerations related to protein production and
degradation, it seems less favourable to have both large amplitude and small period. Given these, whether there are
constraints and/or patterns in the amplitude-period co-variation in biomolecular oscillator models is generally unclear
(Fig. 1).
Here, we investigate the period-amplitude co-variations in biomolecular oscillators. For this, we use mathematical
models of an array of benchmark biomolecular oscillators — Repressilator, Pentilator, Goodwin oscillator, Van der Pol
oscillator, Fitzhugh-Nagumo oscillator, Frzilator, Cyanobacterial circadian oscillator, Metabolator, a mixed feedback
oscillator, Meyer-Stryer model of calcium oscillations and Kim-Forger oscillator — and compute the period and
amplitude of trajectories for different values of parameters around a nominal parameter set, varying parameters one
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Figure 1: Possible period-amplitude co-variations in biomolecular oscillators categorized as Type 0: both amplitude
and period constant/ fixed, Type 1: similar co-variation, Type 2: opposite co-variation, Type 3: constant amplitude,
Type 4: constant period and Type 5: complex.
at a time. We find that the co-variation of the period and amplitude can be similar (Type 1 in Fig. 1), opposite (Type
2), independent where one of the properties is a constant while other varies (Types 3 and 4), or
exhibit a combination of these trends (Type 5). To account for multiple possible biomolecular species in an oscillator,
we quantify amplitude using a power norm, finding largely similar trends. Finally, we analytically approximate a
subset of the oscillator models to calculate ”scaling laws” for the period-amplitude co-variation, finding that as the
approximate period increases, the upper bound of the amplitude increases or reaches a constant (Type 1/ Type 3).
These results provide insight into the period-amplitude co-variation of biomolecular oscillators as well as a reference
for parameters that can be tuned to achieve desired amplitude and frequency.
2 Results
2.1 Simulation of Oscillations
We considered previously developed mathematical models of eleven benchmark oscillators — Repressilator [4], Pen-
tilator [17], Goodwin oscillator [18], Van der Pol oscillator [19], Fitzhugh-Nagumo oscillator [20, 21], Frzilator [22],
Cyanobacterial circadian oscillator [2, 3], Metabolator [23], Mixed feedback oscillator [24, 25], Meyer-Stryer model of
calcium oscillations [26] and Kim-Forger model [27]. Although Van der Pol oscillator is not a biomolecular oscillator,
we note that it is a benchmark nonlinear oscillator and corresponding period-amplitude co-variation is worth inves-
tigating. These models are based on ordinary differential equations (Please see Supplementary material). To obtain
the oscillatory trajectories, these equations were simulated using the MATLAB solvers ode15s and ode23t.
For each oscillator, we plotted the trajectories by varying one parameter at a time over a twofold range around
the nominal value. These are shown in a red-blue colour map with the X-axis representing time, Y-axis representing
parameter value, and the colour representing the instantaneous concentration level along the time axis. We also show
oscillatory trajectories picked for three values in the parameter regime (Please see Supplementary material : Figs.
1-11 A).
2.2 Co-variation of Period and Maximum Amplitude
We begin by computing the co-variation of the period and maximum amplitude. To find the period and amplitude,
we first numerically confirm the existence of oscillations. We define the maximum amplitude as the absolute value
of the difference between the maximum/peak and the minimum/bottom of a periodically oscillating trajectory of
concentration levels. The period is calculated from the average time-interval between five crests. These results are
plotted in Supplementary material (Supplementary Figs. 1-11 B). A zoomed in version of these trends are shown in
Fig. 2. The overall trends are summarized in Table 1 (Columns 2 and 3 in subtables 1a and 1b). The rows where the
maximum amplitude and period exhibit like co-variation are shaded for clarity.
2.3 Co-variation of Period and a Power Norm-based Amplitude Metric
In the above computations, we computed the maximum amplitude based on one biomolecular species, such as the
protein concentration in the Repressilator. The maximum amplitude is a commonly used measure of amplitude (for
example in [17]), which may be due to the direct visual correspondence with the oscillating trajectory. Another
measure used, in the context of a circadian clock, is the square-root of maximum power in the periodogram [28]. A
third measure used, in [29], is the geometric mean of all biomolecular species amplitudes, although it is noted that
other measures may be better. We note that most oscillator models have more than one biomolecular species and
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different period-amplitude co-variations may exist for different biomolecular species. To take these into account, we
consider an amplitude metric based on a power norm [30], which is similar to the one used in [28].
Consider a limit-cycle oscillatory system x˙(t) = f(x, p), where states x ∈ <n and parameter set p ∈ <m, then we
define the power norm in one-cycle duration of T as,
Mp =
√√√√√ 1
T
T∫
0
[
n∑
i=1
x2i (t)]dt, (1)
where xi are the states in differential equation of the oscillator model. Based on this definition, we computed the
co-variation of the period and this amplitude metric. The full simulations are shown in Supplementary (Supplementary
Figs. 1-11 C). A zoomed in version is shown in Fig. 3. The results of these calculations are also summarized in Table
1 (columns 3 and 4 in subtables 1a and 1b) . As before, the rows where the period and this amplitude metric exhibit
like co-variation are shaded for clarity.
These results provide a classification of period-amplitude co-variations in different biomolecular oscillators.
2.4 Co-variation scaling laws
In the above sections we have computed the co-variation of the period and amplitude metrics for different benchmark
oscillators as individual parameters are varied. Next, we investigate this aspect further by focusing on particular
oscillators to get analytical approximations.
Consider the Repressilator, one of the most important benchmark for oscillator designs. As parameters are varied
individually around their default values, the co-variation of period and maximum amplitude take on different shapes.
For example, for the maximal production rate γ, both amplitude and period increase simultaneously (Fig. 2a). For
the protein degradation constant kp, the shape is more complicated. In general, there may be bounds such as on the
maximum achievable amplitude for a given period. To understand this further, we used a framework for analytical
approximations developed where a nonlinear oscillatory system is replaced by a sequence of linear operations for
different parts of the oscillation cycle [31].
For the Repressilator, the approximations to period (Tapprox) and amplitude (Aapprox) are given by,
Tapprox = 3
[
2
ln(2)
km
+
1
kp
(
ln(X) + ln
( X
X − 1
))]
,
Aapprox =
τγ
kpkm
,
(2)
where X =
τγ
√
kb
kpkm
.
The Aapprox is the maximal possible value of the protein concentration. As the minimum value is zero. Aapprox is the
upper bound on the maximum amplitude.
These approximate scaling laws are plotted in Fig. 4a as parameters are varied individually. These show that the
period and maximum amplitude increase or decrease simultaneously, except in cases where the amplitude is constant.
Therefore, the main trend from these scaling laws is that as amplitude increases the period also increases.
We repeated the above exercise for the Pentilator and the Goodwin oscillator. Period (Tapprox) and maximum
amplitude (Aapprox) approximations for Pentilator are given as,
Tapprox = 5
[
2
ln(2)
km
+
1
kp
(
ln(X) + ln
( X
X − 1
))]
,
Aapprox =
τγ
kpkm
,
(3)
where X =
τγ
√
kb
kpkm
.
For Goodwin oscillator, the approximated period (Tapprox) and amplitude (Aapprox) are
Tapprox = 2 ln(2)[
1
k4
+
1
k5
] +
1
k6
[
ln(X) + ln
( X
X − 1
)]
,
Aapprox =
k1k2
k4k5
,
(4)
where X =
k1k2k3
k4k5k6k7
. Using these approximations, we obtained similar conclusions for the Pentilator (Fig. 4b) and
the Goodwin oscillator (Fig. 4c).
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Figure 2: Co-variation of period and maximum amplitude for biomolecular oscillators. In each plot, the point of
intersection of the curves is the center of the black circle which corresponds to the nominal parameter set and the
radius is 10% of oscillation period for nominal parameter set. Circle shaped markers represent the largest value of
the corresponding parameter. a) Repressilator. b) Pentilator. c) Goodwin oscillator. d) Van der Pol oscillator. e)
Fitzhugh-Nagumo oscillator. f) Frzilator. g) Cyanobacteria circadian oscillator. h) Metabolator. i) Mixed feedback
oscillator. j) Meyer-Stryer model of calcium oscillations. k) Kim-Forger model.
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Figure 3: Co-variation of period and amplitude metric (Mp) for biomolecular oscillators. In each plot, the point of
intersection of the curves is the center of the black circle which corresponds to the nominal parameter set and the
radius is 10% of oscillation period for nominal parameter set. Circle shaped markers represent the largest value of
the corresponding parameter. a) Repressilator. b) Pentilator. c) Goodwin oscillator. d) Van der Pol oscillator. e)
Fitzhugh-Nagumo oscillator. f) Frzilator. g) Cyanobacteria circadian oscillator. h) Metabolator. i) Mixed feedback
oscillator. j) Meyer-Stryer model of calcium oscillations. k) Kim-Forger model.
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Table 1: Co-variation of period and amplitude metrics
(1a) For Repressilator, Pentilator, Goodwin oscillator, Van der Pol
oscillator, Fitzhugh-Nagumo oscillator, Frzilator and Cyanobacte-
rial circadian oscillator.
Oscillator/ Maximum Period Metric
Parameters Amplitude Mp
Repressilator
γ Increases Increases Increases
kb Decreases Complex
a Decreases
km Decreases Decreases Decreases
kp Complex
a Decreases Complexa
τ Increases Increases Increases
Pentilator
γ Increases Increases Increases
kb Complex
a Increases Decreases
km Decreases Decreases Decreases
kp Decreases Decreases Decreases
τ Increases Increases Increases
Goodwin oscillator
k1 Complex
b Increases Increases
k2 Increases Constant Increases
k3 Complex
a Constant Increases
k4 Increases Decreases Constant
k5 Complex
b Decreases Decreases
k6 Decreases Decreases Decreases
k7 Complex
b Constant Increases
n Increases Increases Increases
Van der Pol oscillator
µ Constant Increases Constant
ω Constant Decreases Increases
Fitzhugh-Nagumo oscillator
θ Decreases Complexb Decreases
γ Constant Complexb Increases
ω Constant Complexb Increases
φ Constant Decreases Constant
Frzilator
φ Increases Decreases Increases
df Constant Constant Decreases
kc Decreases Decreases Decreases
dc Increases Increases Complex
b
ke Decreases Decreases Decreases
de Constant Constant Constant
Cyanobacteria circadian oscillator
k0UT Constant Constant Constant
k0TD Constant Constant Constant
k0SD Constant Constant Constant
k0US Constant Constant Constant
k0TU Increases Constant Decreases
k0DT Constant Constant Constant
k0DS Decreases Decreases Decreases
k0SU Increases Increases Increases
kAUT Increases Decreases Increases
kATD Increases Decreases Decreases
kASD Increases Increases Increases
kAUS Decreases Decreases Decreases
kATU Decreases Constant Decreases
kADT Increases Increases Increases
kADS Increases Increases Increases
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(1b) For Cyanobacteria circadian oscillator, Metabolator, Mixed
feedback oscillator, Meyer-Stryer model of calcium oscillations and
Kim-Forger oscillator.
Oscillator/ Maximum Period Metric
Parameters Amplitude Mp
Cyanobacteria circadian oscillator
kASU Decreases Decreases Decreases
K1/2 Decreases Decreases Decreases
Metabolator
Vgly Constant Decreases Increases
kTCA Decreases Constant Decreases
k1 Complex
a Decreases Increases
km,1 Constant Constant Constant
k2 Complex
a Decreases Complexa
km,2 Decreases Constant Constant
kAck,f Increases Increases Increases
kAck,r Complex
a Decreases Decreases
C Constant Constant Constant
H+ Constant Constant Constant
Keq Constant Constant Constant
k3 Constant Constant Constant
HOACE Constant Constant Constant
Kg,1 Complex
a Decreases Increases
n Increases Increases Increases
Kg,2 Complex
a Increases Constant
Kg,3 Complex
a Decreases Increases
α0 Complex
a Constant Constant
α1 Complex
a Increases Decreases
α2 Complex
a Decreases Constant
α3 Complex
a Decreases Increases
kd Complex
a Decreases Increases
Mixed feedback oscillator
α Increases Increases Increases
σ Complexa Constant Increases
γx Decreases Decreases Decreases
γy Increases Decreases Increases
τy Increases Increases Constant
Meyer-Stryer model of calcium oscillations
c1 Increases Decreases Decreases
c2 Increases Increases Increases
c3 Constant Decreases Decreases
c4 Complex
a Complexa Decreases
c5 Increases Increases Increases
c6 Decreases Decreases Decreases
c7 Increases Increases Decreases
K1 Increases Increases Increases
K2 Decreases Decreases Decreases
K3 Increases Increases Increases
R Complexa Complexa Decreases
Kim-Forger model
k1 Increases Increases Increases
k2 Increases Increases Increases
k3 Decreases Increases Increases
k4 Complex
a Decreases Complexa
k5 Complex
a Decreases Decreases
k6 Complex
a Decreases Decreases
k7 Increases Decreases Increases
k8 Constant Constant Constant
a First increases then decreases.
b First decreases then increases.
Constant: variations within ±5% from nominal values.
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Figure 4: Analytical approximation of the co-variation between maximum amplitude and period. Dashed lines are
for the numerical solutions of the ODE whereas solid line curves for the analytical approximation for the period
and maximum amplitude. Circle shaped markers represent the largest value of the corresponding parameter. a)
Repressilator. b) Pentilator. c) Goodwin oscillator. Inset shows the zoomed version of the amplitude metric to period
co-variation.
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Table 2: Categorization of Co-variation in period and amplitude
(2a) For Repressilator, Pentilator, Goodwin oscillator, Van
der Pol oscillator, Fitzhugh-Nagumo oscillator, Frzilator and
Cyanobacterial circadian oscillator.
Oscillator/ Maximum Metric
Parameters amplitude Mp
Repressilator
γ, production rate constant Type 1 Type 1
kb, dissociation constant Type 5 Type 5
km, degradation rate constant Type 1 Type 1
kp, degradation rate constant Type 5 Type 5
τ , production rate constant Type 1 Type 1
Pentilator
γ, production rate constant Type 1 Type 1
kb, dissociation constant Type 5 Type 2
km, degradation rate constant Type 1 Type 1
kp, degradation rate constant Type 1 Type 1
τ , production rate constant Type 1 Type 1
Goodwin oscillator
k1, production rate constant Type 5 Type 1
k2, production rate constant Type 4 Type 4
k3, production rate constant Type 5 Type 4
k4, degradation rate constant Type 2 Type 3
k5, degradation rate constant Type 5 Type 1
k6, degradation rate constant Type 1 Type 1
k7, dissociation constant Type 5 Type 2
n, Hill coefficient Type 1 Type 1
Van der Pol oscillator
µ Type 3 Type 3
ω Type 3 Type 2
Fitzhugh-Nagumo oscillator
θ Type 5 Type 5
γ Type 5 Type 5
ω Type 5 Type 5
φ Type 3 Type 3
Frzilator
φ, production rate constant Type 2 Type 2
df , degradation rate constant Type 0 Type 4
kc, production rate constant Type 1 Type 1
dc, degradation rate constant Type 1 Type 5
ke, production rate constant Type 1 Type 1
de, degradation rate constant Type 0 Type 0
Cyanobacteria circadian oscillator
k0UT , inter conversion rate Type 0 Type 0
k0TD, inter conversion rate Type 0 Type 0
k0SD, inter conversion rate Type 0 Type 0
k0US , inter conversion rate Type 0 Type 0
k0TU , inter conversion rate Type 4 Type 4
k0DT , inter conversion rate Type 0 Type 0
k0DS , inter conversion rate Type 1 Type 1
k0SU , inter conversion rate Type 1 Type 1
kAUT , inter conversion rate Type 2 Type 2
kATD, inter conversion rate Type 2 Type 1
kASD, inter conversion rate Type 1 Type 1
kAUS , inter conversion rate Type 1 Type 1
kATU , inter conversion rate Type 4 Type 4
kADT , inter conversion rate Type 1 Type 1
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(2b) For Cyanobacteria circadian oscillator, Metabolator,
Mixed feedback oscillator, Meyer-Stryer model of calcium os-
cillations and Kim-Forger oscillator.
Oscillator/ Maximum Metric
Parameters amplitude Mp
Cyanobacteria circadian oscillator
kADS , inter conversion rate Type 1 Type 1
kASU , inter conversion rate Type 1 Type 1
K1/2, dissociation constant Type 1 Type 1
Metabolator
Vgly, production rate Type 3 Type 2
kTCA, degradation rate constant Type 4 Type 4
k1 Type 5 Type 2
km,1 Type 0 Type 0
k2 Type 5 Type 5
km,2 Type 4 Type 0
kAck,f Type 1 Type 1
kAck,r Type 5 Type 1
C Type 0 Type 0
H+ Type 0 Type 0
Keq Type 0 Type 0
k3, degradation rate constant Type 0 Type 0
HOACE Type 0 Type 0
Kg,1, dissociation constant Type 5 Type 2
n, Hill coefficient Type 1 Type 1
Kg,2, dissociation constant Type 5 Type 3
Kg,3, dissociation constant Type 5 Type 2
α0, leaky coefficient Type 0 Type 0
α1, production rate constant Type 5 Type 2
α2, production rate constant Type 5 Type 4
α3, production rate constant Type 5 Type 2
kd, degradation rate constant Type 5 Type 2
Mixed feedback oscillator
α Type 1 Type 1
σ Type 4 Type 4
γx, degradation rate constant Type 1 Type 1
γy, degradation rate constant Type 2 Type 2
τy Type 1 Type 3
Meyer-Stryer model of calcium oscillations
c1 Type 2 Type 1
c2 Type 1 Type 1
c3 Type 3 Type 1
c4 Type 5 Type 5
c5, degradation rate constant Type 1 Type 1
c6 Type 1 Type 1
c7 Type 1 Type 2
K1, dissociation constant Type 1 Type 1
K2, dissociation constant Type 1 Type 1
K3, dissociation constant Type 1 Type 1
R, production rate constant Type 5 Type 5
Kim-Forger model
k1, production rate constant Type 1 Type 1
k2, production rate constant Type 1 Type 1
k3, production rate constant Type 2 Type 1
k4, degradation rate constant Type 5 Type 5
k5, degradation rate constant Type 5 Type 1
k6, degradation rate constant Type 5 Type 1
k7 Type 2 Type 2
k8, dissociation constant Type 0 Type 0
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3 Discussion
Understanding design principles underlying operation of biomolecular oscillators is an important challenge. Using
computational models of benchmark oscillators — Repressilator, Pentilator, Goodwin oscillator, Van der Pol oscillator,
Fitzhugh-Nagumo oscillator, Frzilator, Cyanobacterial circadian oscillator, Metabolator, a mixed feedback oscillator
and Meyer-Stryer model of calcium oscillations and Kim-Forger model — we present an investigation of the co-variation
of period and amplitude. First, we plot the maximum amplitude versus the period as each parameter is individually
varied in a range around the nominal value, finding a range of curves showing both mutually increasing as well as
other trends. Second, noting that the maximum amplitude metric considers a single state, we adapted a metric based
on the power of a multivariable output signal and plotted these against the period, finding largely similar co-variation
trends. Third, we analytically approximate three oscillator models to obtain ”scaling laws” for the period-amplitude
co-variation, finding that as approximate period increases the upper bound of maximum amplitude always increases
(or remains constant). These results provide an insight into the functioning of biomolecular oscillators as well as a
reference to choose specified amplitude-period values for design applications.
We note how the scaling laws obtained show that, throughout the parameter space where oscillations persist, as
the approximation to the period increases, the upper bound on the maximum amplitude either increases or, due to
saturation effects, reaches a constant. This is consistent with a Type 1, or Type 3 behaviour. This analysis also
underlines that the region in period-amplitude space where the period is low and amplitude is high is hard to access,
denoted ‘Forbidden Region’ in Fig. 1. The actual co-variation of the period and amplitude as a function of the variation
of the parameters may have more complex patterns away from the Forbidden Region. Based on the computations
presented above, we discuss these patterns (Table 2) below.
Production Rate: The production rate controls the extent of the production of the protein. As this increases, we
expect the maximum amplitude to increase. Further, other parameters being equal, we expect an increase in the period
on account of the extra time that may be required for the biomolecules to reach the higher amplitude levels. The
simultaneous increase in period and amplitude should classify this as Type 1 behaviour, or a Type 3 behaviour in case
saturation effects dominate. For the Repressilator, we found that the production rate constants γ and τ exhibited a
Type 1 co-variation between the period and the maximum amplitude. Similar trends were observed for the Pentilator.
However, for other cases, such as the production rate constants k1 and k3 in the Goodwin oscillator, other types of
co-variations are observed. This could be because of dual dynamical effects of the production rate. For example, an
increase in production rate may trigger a downstream repressor that may reduce the maximum amplitude. Out of
the 18 instances when the parameter can be classified as a production rate constant, there were 9 instances of the
production rate constant exhibiting a Type 1 or Type 3 behaviour in the co-variation of the period and the maximum
amplitude.
Degradation Rate: The degradation rate constant is a parameter that controls the rate at which a biomolecule
degrades. We expect that as this increases, the maximum amplitude possible should decrease. Further, we expect that
the period should also decrease, both from the point of view of the lower amplitudes that needs to be reached as well
as from the point of view the effect on the time constant of the system. The time constant is inversely proportional
to the degradation rate constant, and as this rate increases, the time constant reduces, or response speeds up. Again,
this is an example of a Type 1 behaviour as both the maximum amplitude and period simultaneously decrease. For
the Repressilator, we found that the degradation rate constant km exhibited a Type 1 co-variation between the period
and the maximum amplitude. However, for the degradation constant kp, a complex co-variation pattern (Type 5) was
observed, possibly due to a dual effect of the parameter. For Pentilator, on the other hand, both the degradation rate
constants exhibited Type 1 behaviour. For other oscillators, among 15 instances of degradation rate constant, there
were 5 instances of Type 1 co-variation between the period and the maximum amplitude.
Dissociation Constant: The dissociation constant reflects the rate at which the activation/ repression of a biomolecule
is at half its maximum rate.bAs this increases, we expect that the amplitude also increases, owing to the need for
biomolecules to reach higher levels to trigger activation/ repression. We expect that reaching higher amplitude may
take more time and so the period should increase. Therefore, these expectations are of a Type 1 behaviour.
However, we found that the dissociation constant (1/kb) in the Repressilator and the Pentilator as well as the
dissociation constant k7 in the Goodwin oscillator exhibited complex co-variation (Type 5) behaviour.Perhaps in some
parameter regime, there is a dual effect of this parameter.
Finally, we note how different mechanisms underlying circadian oscillations can have a similar period-amplitude
co-variation. In the context of circadian clocks, the negative feedback may be implemented by a protein sequestration-
based mechanism as well as a Hill-type repression mechanism, as in the Kim-Forger model and the Goodwin model,
respectively [18,27]. The key difference between the two models is the production term for the mRNA, which is either
a Hill-type repression or a protein sequestration-based mechanism. When we compare period-amplitude co-variations
of these two models, for the nominal parameter sets, we find certain similarities as well as differences. On the one
hand, the quantitative nature of the co-variations are different, with the same parameter giving different trends. For
example, as the degradation rate constant k5 is increased, the period decreases in both models. However, for the
Goodwin oscillator, the maximum amplitude first decreases, then increases, whereas for the Kim-Forger oscillator the
opposite happens (Please see Supplementary material: Figs. 3B, 11B). On the other hand, on a closer look, we find
that both models can have the property that the amplitude can be tuned while the period does not change significantly
using same parameters (k2, k3, k7). Similarly, both models can have the property that the period, and to some extent
11
the amplitude, can be tuned using same parameters (k4, k5, k6), all of which are related to the degradation reaction.
Further, the scaling laws for the Kim-Forger oscillator are similar to that of the Goodwin oscillator if the upper bound
for the amplitude is assumed conservatively. This is consistent with the presence of a ‘forbidden region’ indicating that
achieving large amplitude small period oscillations may be difficult. These similarities could be because of the fact
that, despite different biomolecular mechanisms, they have similar mathematical representations at the systems-level.
It also points to similar constraints that may have shaped their evolution.
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